coronavirus 2
Showing 1 - 25 of >10,000
Assess Infection Rate of Severe Acute Respiratory Syndrome -
Completed
- Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)
-
Chicago, IllinoisGreat Lakes Clinical Trials /ID# 224874
Oct 6, 2022
Antigen Rapid Diagnostic Tests for Community Identification of
Recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- Rapid Antigen Testing
-
Kiambu, KenyaKiambu County
Jul 12, 2022
Anosmia Trial (platelets rich plasma)
Not yet recruiting
- Anosmia
- platelets rich plasma
- (no location specified)
May 25, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in
Not yet recruiting
- Systemic Sclerosis
- SARS-CoV 2 Vaccination
- (no location specified)
Jul 24, 2023
How Future Surgery Will Benefit From Severe Acute Respiratory
Completed
- COVID-19
- Health Behavior
- COVID-surg-SPIGC questionnaire
-
Roma, Rome, Italy
- +2 more
Nov 17, 2022
Covid19, Hypertension, Corona Persistent Symptoms Trial in Giza (Inspiratory muscle trainer, diaphragmatic release)
Enrolling by invitation
- Covid19
- +2 more
- Inspiratory muscle trainer
- diaphragmatic release
-
Giza, Dokki, EgyptFaculty of Physical Therapy
Jun 17, 2022
Covid19 Trial in Nedlands (anti-SARS-CoV-2 IgY, Placebo)
Completed
- Covid19
- anti-SARS-CoV-2 IgY
- Placebo
-
Nedlands, Western Australia, AustraliaLinear Clinical Research - Harry Perkins Research Institute
Jun 30, 2022
SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver
Completed
- Non-Alcoholic Fatty Liver Disease
- SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2) LIFESTYLE CHANGES
-
Naples, ItalyUniversity of Campania "Luigi Vanvitelli"
Jun 9, 2022
COVID-19 Biological Samples Collection
Recruiting
- Infection Viral
- biological samples collection
-
Bordeaux, FranceCentre Hospitalier Universitaire de Bordeaux
Dec 7, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Ferrara (SARS-Cov-2 infection)
Recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- SARS-Cov-2 infection
-
Ferrara, ItalyAzienda Ospedaliera Universitaria di Ferrara
Nov 1, 2022
Severe Exacerbation of Severe Acute Respiratory Syndrome
Active, not recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co. Ltd.,
Jun 5, 2023
Nutritional Indices on the Prognosis of SARS-CoV-2 Infection
Recruiting
- COVID-19
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
Apr 27, 2023
COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Trial in Spain (C19-IG 20%, 0.9% Sodium
Terminated
- COVID-19
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- C19-IG 20%
- 0.9% Sodium chloride
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +11 more
Nov 8, 2022
SARS CoV-2 Post-Acute Sequelae Trial in Birmingham (DPA-714 PET/MRI)
Not yet recruiting
- SARS CoV-2 Post-Acute Sequelae
- DPA-714 PET/MRI
-
Birmingham, AlabamaUAB
Dec 16, 2022
Japan After Severe Acute Respiratory Syndrome Coronavirus 2
Not yet recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co., Ltd
Jun 6, 2023
Among Healthcare Workers for SARS-Coronavirus-2 Infection
Recruiting
- COVID-19
- SARS-CoV2 Infection
-
Johannesburg, GP, South AfricaChris Hani Baragwanath Academic Hospital
Jan 2, 2022
Vaccination Hesitancy Trial in Oklahoma City, Stillwater (Standard MI, Intensive MI, MOTIVACC)
Not yet recruiting
- Vaccination Hesitancy
- Standard MI
- +3 more
-
Oklahoma City, Oklahoma
- +1 more
Aug 2, 2023
COVID-19 Trial in New York (Hydroxychloroquine (HCQ))
Completed
- COVID-19
- Hydroxychloroquine (HCQ)
-
New York, New YorkNYU Langone Health
Dec 12, 2022
Covid19, SARS (Severe Acute Respiratory Syndrome) Trial (Hydroxychloroquine, Vitamins and Minerals, Azithromycin)
Withdrawn
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- Hydroxychloroquine
- +2 more
- (no location specified)
Dec 5, 2021
COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)
Not yet recruiting
- COVID-19 Infection
- COVID-19 Vaccine Adverse Reaction
- LEM-mR203
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital Clinical Trials Center
Sep 12, 2023
Covid19, Coronavirus Trial in London (Corsodyl® Alcohol free -0.2 % Chlorhexidine digluconate, Colgate Peroxyl® -1.5% Hydrogen
Completed
- Covid19
- Coronavirus
- Corsodyl® Alcohol free -0.2 % Chlorhexidine digluconate
- +3 more
-
London, United Kingdom
- +1 more
Sep 12, 2022
COVID-19, SARS-CoV-2 Acute Respiratory Disease Trial in Hanoi (COVID-19 Vaccine HIPRA, Cominarty (Pfizer-BioNtech))
Active, not recruiting
- COVID-19
- SARS-CoV-2 Acute Respiratory Disease
- COVID-19 Vaccine HIPRA
- Cominarty (Pfizer-BioNtech)
-
Hanoi, VietnamNational Institute of Hygiene and Epidemiology
Aug 2, 2022
Japan of Shock and Anaphylaxis After Severe Acute Respiratory
Active, not recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co., Ltd.
Jun 5, 2023
Hypoxia, SARS-CoV-2 Acute Respiratory Disease, Carotid Bodies Trial in Chicago (Phase-1: Breath Holding Test, Phase 2: 6-Minute
Completed
- Hypoxia
- +2 more
- Phase-1: Breath Holding Test
- Phase 2: 6-Minute Walk Test (6MWT)
-
Chicago, IllinoisUniversity of Chicago Medical Center
Apr 26, 2022
Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder) Trial (MBS-COV, Placebo)
Not yet recruiting
- Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
- MBS-COV
- Placebo
- (no location specified)
Jul 11, 2023